Management of Endometriosis: Toward Value-Based, Cost-Effective, Affordable Care

Paolo Vercellini, Facchin F, Federica Facchin, Laura Buggio, Buggio L, Giussy Barbàra, Giussy Barbara, Berlanda N, Nicola Berlanda, Maria Pina Frattaruolo, Frattaruolo MP, Somigliana E, Edgardo Somigliana
Journal of obstetrics and gynaecology Canada : JOGC = Journal d'obstetrique et gynecologie du Canada : JOGC · 2017 · vol. 40(6) , pp. 726–749.e10 · doi:10.1016/j.jogc.2017.07.011 · PMID:28988744 · W2761947111
review OA: green CC0 ⤵ 26 in-corpus citations
🔓 Open OA copy View on OpenAlex View on PubMed View at publisher
⚙ AI-generated summary by gemini-2.5-flash-lite, 2026-06-08 ⓘ

This paper explores strategies for achieving value-based, cost-effective, and affordable management of endometriosis to improve patient care.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

Abstract

Endometriosis management seems to be influenced by outcome-independent biomedical, pharmacological, and technological developments. The propensity towards doing more affects several aspects of care, sometimes translating into proposals that are not based on sound epidemiological principles and robust evidence. Different stakeholders share the interest for doing more testing and using novel and costly drugs or devices in patients with endometriosis. Although some women may benefit from such an approach, the majority do not, and some may be harmed. Moreover, an uncontrolled increase in expenditures for endometriosis management without demonstrated and proportional health benefits would waste the finite resources of national health care services and would risk cost-related non-adherence. Cost-effectiveness analyses should be systematically pre-planned in future trials on endometriosis, and the concept of "value" of medical interventions should guide investigators and health care policymakers. Reducing low-value care, financial toxicity, and the burden of treatment is respectful not only of endometriosis patients, but also of the entire society. Whenever possible, long-term therapeutic strategies should be tailored to each woman's needs, and high-value tests and treatments should be chosen based on her priorities and preferences. Moreover, listening to patients, understanding their concerns, avoiding disease labelling, explaining plainly what is known and what is unknown, and giving constant reassurance and encouragement may be exceedingly important for the successful management of endometriosis and may change the patient's perception of her clinical condition. Physician empathy has no untoward effects, does not cause harms, and may determine whether a woman successfully copes or desperately struggles with her disease during reproductive life.

My notes (saved in your browser only)

Condition tags

endometriosis

MeSH descriptors

Cost-Benefit Analysis Costs and Cost Analysis Endometriosis Adolescent Conflict of Interest Endometriosis Endometriosis Endometriosis Female Fertilization in Vitro Health Priorities Hormone Replacement Therapy Humans Infertility, Female Infertility, Female Menopause Ovarian Neoplasms Ovarian Neoplasms Ovariectomy Pain Management

Citation neighborhood

Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. [ expand to 2 hops ] — adds papers reached through this work's immediate citers/citees. Heavier; up to 60 extra dots.

References (100)

Cited by (27)

Source provenance

europepmc
last seen: 2026-08-23T09:30:01.253652+00:00
openalex
last seen: 2026-06-10T17:14:06.276822+00:00
pubmed
last seen: 2026-05-13T22:20:13.663096+00:00
License: CC0 · commercial use OK